Renben Wang
Impact in
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 7
- Oncology 18
- Colorectal Cancer Surgical Treatments 12
- Colorectal Cancer Screening and Detection 4
- Cancer Immunotherapy and Biomarkers 3
- Journals
- Medical Oncology (3 papers)Radiation Oncology (3 papers)Cancer Biomarkers (2 papers)OncoTargets and Therapy (2 papers)BioScience Trends (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Renben Wang
28 papers receiving 554 citations
Peers
Comparison fields: 5 of 59
- Radiation 109
- Oncology 256
- Pulmonary and Respiratory Medicine 249
- Hepatology 59
- Cancer Research 96
Countries citing papers authored by Renben Wang
This map shows the geographic impact of Renben Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renben Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renben Wang more than expected).
Fields of papers citing papers by Renben Wang
This network shows the impact of papers produced by Renben Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renben Wang. The network helps show where Renben Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Renben Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 3 | |
| 2 | 2017 | 58 | |
| 3 | 2016 | 12 | |
| 4 | 2016 | 64 | |
| 5 | 2016 | 3 | |
| 6 | 2015 | 9 | |
| 7 | 2014 | 18 | |
| 8 | 2014 | 7 | |
| 9 | 2014 | 13 | |
| 10 | 2014 | 16 | |
| 11 | 2014 | 20 | |
| 12 | 2014 | 25 | |
| 13 | 2013 | 7 | |
| 14 | 2013 | 11 | |
| 15 | 2013 | 7 | |
| 16 | 2012 | 11 | |
| 17 | Cytokeratin 19 fragment antigen 21-1 as an independent predictor for definitive chemoradiotherapy sensitivity in esophageal squamous cell carcinoma. | 2012 | 16 |
| 18 | 2011 | 8 | |
| 19 | 2010 | 12 | |
| 20 | 2007 | 163 |
About Renben Wang
Renben Wang is a scholar working on Hepatology, Oncology, Radiation, Pulmonary and Respiratory Medicine and Surgery, having authored 28 papers that have together received 567 indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Colorectal and Anal Carcinomas (6 papers), Genetic factors in colorectal cancer (4 papers), Colorectal Cancer Screening and Detection (4 papers), Advanced Radiotherapy Techniques (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Esophageal Cancer Research and Treatment (3 papers). The work is most often cited by research in Radiation (109 citations), Oncology (256 citations), Pulmonary and Respiratory Medicine (249 citations), Hepatology (59 citations) and Cancer Research (96 citations). Renben Wang has collaborated with scholars based in China and United States. Frequent co-authors include Hongjiang Yan, Shumei Jiang, Xiaoqing Xu, Kunli Zhu, Jinming Yu, Xiangjiao Meng, Yong Yin, Minghuan Li, Jianbin Li and Baosheng Li. Their work appears in journals such as Medical Oncology, Radiation Oncology, Cancer Biomarkers, OncoTargets and Therapy and BioScience Trends.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.